BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30239030)

  • 1. Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma.
    Stanoszek LM; Chan MP; Palanisamy N; Carskadon S; Siddiqui J; Patel RM; Harms KL; Lowe L; Fullen DR; Harms PW
    Histopathology; 2019 Feb; 74(3):504-513. PubMed ID: 30239030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites.
    Chan JK; Suster S; Wenig BM; Tsang WY; Chan JB; Lau AL
    Am J Surg Pathol; 1997 Feb; 21(2):226-34. PubMed ID: 9042291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral cavity neuroendocrine carcinoma: a comparison study with cutaneous Merkel cell carcinoma and other mucosal head and neck neuroendocrine carcinomas.
    Lewis JS; Duncavage E; Klonowski PW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):209-17. PubMed ID: 20659699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating Merkel cell carcinoma of lymph nodes without a detectable primary skin tumor from other metastatic neuroendocrine carcinomas: The ELECTHIP criteria.
    Kervarrec T; Zaragoza J; Gaboriaud P; Le Gouge A; Beby-Defaux A; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Michenet P; Maillard H; Touzé A; Samimi M; Guyétant S
    J Am Acad Dermatol; 2018 May; 78(5):964-972.e3. PubMed ID: 29180096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SATB2, CKAE1/AE3, and synaptophysin as a sensitive immunohistochemical panel for the detection of lymph node metastases of Merkel cell carcinoma.
    Szumera-Cieckiewicz A; Massi D; Cassisa A; Krzyzinski M; Dudzisz-Sledz M; Biecek P; Rutkowski P; Marszalek A; Hoang MP; Donizy P
    Virchows Arch; 2024 Apr; 484(4):629-636. PubMed ID: 38066198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas.
    Kervarrec T; Tallet A; Miquelestorena-Standley E; Houben R; Schrama D; Gambichler T; Berthon P; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Tabareau-Delalande F; Beneton N; Fromont G; Arbion F; Leteurtre E; Touzé A; Samimi M; Guyétant S
    Mod Pathol; 2019 Apr; 32(4):499-510. PubMed ID: 30349028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent expression of glypican-3 in Merkel cell carcinoma: an immunohistochemical study of 55 cases.
    He H; Fang W; Liu X; Weiss LM; Chu PG
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):40-6. PubMed ID: 18813128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical profiles of different subsets of Merkel cell carcinoma.
    Pasternak S; Carter MD; Ly TY; Doucette S; Walsh NM
    Hum Pathol; 2018 Dec; 82():232-238. PubMed ID: 30067951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.
    Pulitzer MP; Brannon AR; Berger MF; Louis P; Scott SN; Jungbluth AA; Coit DG; Brownell I; Busam KJ
    Mod Pathol; 2015 Aug; 28(8):1023-32. PubMed ID: 26022453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma.
    Lilo MT; Chen Y; LeBlanc RE
    Am J Surg Pathol; 2018 Nov; 42(11):1541-1548. PubMed ID: 30080705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin.
    Nicholson SA; McDermott MB; Swanson PE; Wick MR
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):37-41. PubMed ID: 10937047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous metastases of pancreatic neuroendocrine carcinoma.
    Laschinger ME; Naga L; Gaspari AA
    G Ital Dermatol Venereol; 2018 Oct; 153(5):722-724. PubMed ID: 30246953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel cell carcinoma with an unusual immunohistochemical profile.
    Pilloni L; Manieli C; Senes G; Ribuffo D; Faa G
    Eur J Histochem; 2009 Dec; 53(4):e33. PubMed ID: 22073365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1.
    Leech SN; Kolar AJ; Barrett PD; Sinclair SA; Leonard N
    J Clin Pathol; 2001 Sep; 54(9):727-9. PubMed ID: 11533085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SATB2 is expressed in Merkel cell carcinoma.
    Fukuhara M; Agnarsdóttir M; Edqvist PH; Coter A; Ponten F
    Arch Dermatol Res; 2016 Aug; 308(6):449-54. PubMed ID: 27262585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Case of CK20/CK7 Double Negative Merkel Cell Carcinoma.
    Le MD; OʼSteen LH; Cassarino DS
    Am J Dermatopathol; 2017 Mar; 39(3):208-211. PubMed ID: 28221211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of microtubule-associated protein-2 in Merkel cell carcinoma.
    Liu Y; Mangini J; Saad R; Silverman AR; Abell E; Tung MY; Graner SR; Silverman JF
    Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):326-9. PubMed ID: 14663358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
    Cho WC; Vanderbeck K; Nagarajan P; Milton DR; Gill P; Wang WL; Curry JL; Torres-Cabala CA; Ivan D; Prieto VG; Aung PP
    Arch Pathol Lab Med; 2023 Jul; 147(7):758-766. PubMed ID: 36745184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.
    Harms PW; Collie AM; Hovelson DH; Cani AK; Verhaegen ME; Patel RM; Fullen DR; Omata K; Dlugosz AA; Tomlins SA; Billings SD
    Mod Pathol; 2016 Mar; 29(3):240-8. PubMed ID: 26743471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.